Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Chest pain is a rare manifestation of hypocalcemia. Primary hypoparathyroidism, characterized by low parathyroid hormone levels, high serum phosphorous, low serum calcium and normal magnesium levels, represents a rare and uncommon cause.
Patient concerns: A 54-year-old East African male with no comorbidities, no significant family history and no surgical history, presented with acute and severe left-sided chest pain radiating to the left shoulder and jaw for two hours mimicking acute coronary syndrome. Acute coronary syndrome, renal failure, pulmonary embolism, aortic dissection, pseudo and pseudopseudo-hypoparathyroidism were ruled out. Chvostek and Trosseau’s signs were positive, other physical exam was unremarkable. Laboratory findings were as follows: Serum calcium levels were low at 1.14 mmol/l, serum phosphorous was high at 2.78 mmol/l, parathyroid hormone level was low at 4pg/ml, and serum magnesium levels were normal at 0.73mmol/l.
Diagnosis: Primary hypoparathyroidism based on clinical presentation, low parathyroid hormone levels, low serum calcium levels, and elevated serum phosphorous. Urine electrolytes were not measured due to cost constraints.
Interventions: Intravenous 10% calcium gluconate bolus, oral calcium and sevelamer.
Outcomes: Resolution of chest pain and neuro-muscular irritability immediately after initiation of treatment. Subsequently serum calcium levels normalized to 2.4 mmol/l, phosphorous reduced to 1.3 mmol/l, magnesium remained normal at 0.68 mmol/l while parathyroid hormone levels remained low at 4pg/ml .
Take-home lessons: This case underscores the importance of recognizing atypical presentations of hypocalcemia and primary hypoparathyroidism.
